HealthCare Plus 24: Julie-Ann Cabana—A Visionary at the Intersection of Science and Strategy
Subretinal Injection of Sodium Iodate Creates a Geographic Atrophy-Like Model in Nanopigs™
Evaluation of Formulation pH Tolerability in New Zealand White and Dutch Belted Rabbits Post-Intravitreal Administration
A 13-Week Dermal Toxicity Study of VIM-004 Gel, a STAR Particles Based Formulation in Göttingen Minipigs®
Targeted Gene Therapy for CNS Disorders: Precision of Intra-Cerebroventricular (ICV) Delivery and Post-Administration Behavioral Assessments in Mice
Bestrophin-Like Lesions Described in Dutch Belted Rabbits
Standardization and Harmonization of Altasciences Historical Control Database Development Using Certara SEND Explorer® for Integrated Toxicological Evaluation
Gene Therapy Studies and Germline Integration Assessment in Nonhuman Primates
Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD
Many of my colleagues and I are members of the Cross-Company Abuse Liability Council (CCALC), where I have been a co-chair for the past seven years, and a member for 15.
Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development
The unique physicochemical properties of oligonucleotides require the use of specialized bioanalytical approaches, with key considerations including selectivity and specificity, sensitivity, stability, and matrix effects.